Shanghai, China, and Ingelheim, Germany, 14 December 2011 – Boehringer Ingelheim announced today that the company intends to invest 70 million Euro to expand its manufacturing plant in the Zhangjiang High-Tech Park in Shanghai into a strategically important supply center for China. The goal of this project is to bring more health to more patients and to continuously improve Boehringer Ingelheim’s product competitiveness and enlarge its market share.
With the expansion until end of 2013, the number of employees will rise significantly from 240 today to 400, the production capacity will be doubled.
